EMA Withdrawn: Clopidogrel Qualimed (clopidogrel (as hydrochloride)) — Qualimed

View source ↗

Summary

EMA withdrew Clopidogrel Qualimed (clopidogrel hydrochloride) from the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Peripheral Vascular Diseases
• Stroke

Drugs mentioned

• Clopidogrel Qualimed (clopidogrel (as hydrochloride))

Snippet

Status: Withdrawn. Therapeutic area: Peripheral Vascular Diseases;Stroke;Myocardial Infarction. MAH: Qualimed. Decision date: 01/09/2014